BioSpace News Archive

CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that it has closed its Series B funding round

The Allen Institute today announced the launch of the Allen Institute for Immunology, a new division of the Institute that is dedicated to studying the human immune system.

Solidarity HealthShare is reminding health insurance consumers they have a more affordable option when choosing health insurance, an alternative that doesn’t pay for abortion.

New Rhein Healthcare Investors, an international private equity firm has announced moving its global headquarters from Chicago to Philadelphia, complementing its other offices in Brussels and London.

Everett Stern, the whistleblower who uncovered major financial crimes at one of the world’s largest banks, today released a detailed report accusing the Michigan Department of Health & Human Services (MDHHS) of fraud.

Boca West Children’s Foundation (BWCF), which identifies and funds projects and programming assisting at-risk children and their families in Palm Beach County, will tap the resources of Florida Atlantic University (FAU) marketing students to help spread Foundation awareness.

Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) introduced today the logo design for its Hemp4mula CBD infused candies and vapes.

The 2019 open enrollment deadline is quickly approaching on Dec. 15, meaning it’s crunch time for employers to finalize how they’ll ideally save money for their businesses while also providing better health benefits for employees.

Sinovac Biotech Ltd. (“Sinovac” or the “Company”) announced that the People’s Court in Haidian District, Beijing (the “Court”), has issued an interim injunction order restraining Mr. Aihua Pan from using or authorizing others to use the business license, corporate seal (No.: 1101081347485), contract seal and invoice seal of the Company’s subsidiary, Sinovac Biotech Co., Ltd (“Sinovac Beijing”), that were improperly obtained by him.

The Medicines Company (NASDAQ:MDCO) (the “Company”) today announced that it proposes to offer $150 million aggregate principal amount of convertible senior notes due 2024, subject to market conditions and other factors.